Información del artículo
Abstract
Introduction
Fragile X syndrome is an inherited form of mental retardation. It results from an abnormally expanded number of trinucleotide CGG repeats. Some grandfathers of these children become forgetful, have frequent falls and other neurological problems. Researchers have found a connection between fragile X syndrome and the neurological symptoms in elderly men. This resulted in the recognition of a syndrome originally referred to as “intention tremor, parkinsonism and generalised brain atrophy in carriers of a fragile X premutation”. This premutation is also associated with premature ovarian failure.
MethodologyThis paper reviews the literature on the neurological signs of fragile X premutation.
ConclusionsFragile X premutation is a risk for movement disorders and cognitive dysfunction and it should be considered in patients with a family history of mental retardation or autism, and particularly in those females with premature ovarian failure.
Keywords:
Fragile X premutation
Tremor/ataxia syndrome
Parkinsonism
Cognitive deficit
Resumen
Introducción
El síndrome X frágil es una forma de retraso mental heredado. Es consecuencia de una expansión anormal del número de repeticiones del trinucleótido CGG. Algunos abuelos de estos niños llegan a ser olvidadizos, tienen frecuentes caídas y sufren otros problemas neurológicos. Los investigadores han encontrado una conexión entre el síndrome X frágil y los síntomas neurológicos de los ancianos. Esto ha llevado a reconocer un síndrome inicialmente denominado “temblor intencional, parkinsonismo y atrofia cerebral generalizada en portadores de premutación X frágil”. Al mismo tiempo, en las mujeres, la premutación se ha asociado a fallo ovárico prematuro.
MetodologíaEste artículo revisa la bibliografía acerca de las manifestaciones neurológicas de la premutación X frágil.
ConclusionesLa premutación X frágil supone un riesgo de sufrir trastornos del movimiento y disfunciones cognitivas y debe considerarse en pacientes con una historia familiar de retraso mental o autismo y, particularmente, en mujeres con fallo ovárico prematuro.
Palabras clave:
Premutación X frágil
Síndrome temblor/ataxia
Parkinsonismo
Deterioro cognitivo
El Texto completo está disponible en PDF
References
[1.]
R.J. Hagerman, K. Amiri, A. Cronister.
Fragile X checklist.
Am J Med Genet, 38 (1991), pp. 283-287
[2.]
R.F. Kooy, R. Willemsen, B.A. Oostra.
Fragile X syndrome at the turn of the century.
Mol Med Today, 6 (2000), pp. 193-198
[3.]
P.J. Hagerman, R.J. Hagerman.
The fragile x premutation: a maturing perspective.
Am J Hum Genetics, 74 (2004), pp. 805-816
[4.]
S.L. Nolin, W.T. Brown, A. Glicksman, G.E. Houck, A.D. Gargano, A. Sullivan, et al.
Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles.
Am J Hum Genet, 72 (2003), pp. 454-464
[5.]
B. Bardoni, J.L. Mandel, G.S. Fisch.
FMR1 and the fragile X syndrome.
Am J Med Genet, 97 (2000), pp. 153-163
[6.]
P. Jin, S.T. Warren.
Understanding the molecular basis of fragile X syndrome.
Hum Mol Genet, 9 (2000), pp. 901-908
[7.]
A.L. Ludwig, C. Raske, F. Tassone, D. Garcia-Arocena, J.W. Hershey, P.J. Hagerman.
Translation of the FMR1 mRNA is not influenced by AGG interruptions.
Nuc Acids Res, 37 (2009), pp. 6896-6904
[8.]
A.O.H. Nygren, S.I. Lens, R.J. Carvalho.
Methylation-specific multiplex ligation-dependent probe amplification enables a rapid and reliable distinction between male FMR1 premutation and full mutation alleles.
Mol Diagn, 10 (2008), pp. 496-501
[9.]
R.J. Hagerman, P.J. Hagerman.
The fragile X premutation: into the phenotypic fold.
Curr Op Genet Dev, 12 (2002), pp. 278-283
[10.]
C. Dombrowski, S. Lévesque, M.L. Morel, P. Rouillard, K. Morgan, F. Rousseau.
Premutation and intermediate-size FMR1 alleles in 10.572 males form the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles.
Hum Mol Genet, 11 (2002), pp. 371-378
[11.]
S.D. Koukoui, A. Chaudhuri.
Neuroanatomical, molecular genetic and behavioural correlates on fragile X syndrome.
Brain Res Rev, 53 (2007), pp. 27-38
[12.]
R. Willemsen, B.A. Oostra, G.J. Bassell, J. Dictenberg.
The fragile X syndrome: from molecular genetics to neurobiology.
Ment Retard Develop Disabil Res Rev, 10 (2004), pp. 60-67
[13.]
S.K. Koekkoek, K. Yamaguchi, B.A. Milojkovic, B.R. Dortland, T.J. Ruigrok, R. Maex, et al.
Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome.
Neuron, 47 (2005), pp. 339-345
[14.]
S.A. Irwin, R. Galvez, W.T. Greenough.
Dendritic spine structural anomalies in fragile-X mental retardation syndrome.
Cereb Cortex, 10 (2000), pp. 1038-1044
[15.]
G. Stefani, C.E. Fraser, J.C. Darnell, R.B. Darnell.
Fragile X mental retardation protein is associated with translating polyribosomes in neuronal cells.
J Neurosci, 24 (2004), pp. 9272-9276
[16.]
S.H. Mostofsky, M.M. Mazzocco, G. Aakalu, I.S. Warsofsky, M.B. Denckla, A.L. Reiss.
Decreased cerebellar posterior vermis size in fragile X syndrome: correlation with neurocognitive performance.
Neurology, 50 (1998), pp. 121-130
[17.]
S. Eliez, C.M. Blasey, L.S. Freund, T. Hastie, A.L. Raiss.
Brain anatomy, gender and IQ in children and adolescents with fragile X syndrome.
Brain, 124 (2001), pp. 1610-1618
[18.]
A. Kenneson, F. Zhang, C.H. Hagedorn, S.T. Warren.
Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers.
Hum Mol Genet, 10 (2001), pp. 1449-1454
[19.]
F. Tassone, R.J. Hagerman, A.K. Taylor, L.W. Gane, T.E. Godfrey, P.J. Hagerman.
Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome.
Am J Hum Genet, 66 (2000), pp. 6-15
[20.]
B. Bardoni, J.L. Mandel.
Advances in understanding of fragile X pathogenesis and FMRP function and in identification of X linked mental retardation genes.
Curr Op Genet Dev, 12 (2002), pp. 284-293
[21.]
C.M. Greco, R.J. Hagerman, F. Tassone, A. Chudley, M.R. Del Bigio, S. Jacquemont, et al.
Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers.
Brain, 125 (2002), pp. 1760-1771
[22.]
R.J. Hagerman, B.R. Leavitt, F. Farzin, S. Jacquemont, C.M. Greco, J.A. Brunberg, et al.
Fragile-X associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation.
Am J Hum Genet, 74 (2004), pp. 1051-1056
[23.]
M. Gokden, J.T. Al-Hinti, S.I. Harik.
Peripheral nervous system pathology in fragile X tremor/ataxia syndrome (FXTAS).
Neuropathology, 6 (2008), pp. 1-5
[24.]
C.M. Greco, R.F. Berman, R.M. Martin, F. Tassone, P.H. Schwartz, A. Chang, et al.
Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS).
Brain, 129 (2006), pp. 243-255
[25.]
S. Cohen, K. Masyn, J. Adams, D. Hessl, S. Rivera, F. Tassone, et al.
Molecular and imaging correlates of the fragile X-associated tremor/ataxia syndrome.
Neurology, 67 (2006), pp. 1426-1431
[26.]
J.R. Brouwer, K. Huizer, L.A. Severijnen, R.K. Hukema, R.F. Berman, B.A. Oostra, et al.
CGG-repeat length and neuropathological and molecular correlates in a mouse model for fragile X-associated tremor/ataxia syndrome.
J Neurochem, 107 (2008), pp. 1671-1682
[27.]
E. Reyniers, J.J. Martin, P. Cras.
Postmorten examination of two fragile X brothers with an FMR1 full mutation.
Am J Med Genet, 84 (1999), pp. 245-249
[28.]
C.M. Greco, F. Tassone, D. Garcia-Arocena, N. Tartaglia, S.M. Coffey, T.K. Vartanian, et al.
Clinical and neuropathologic findings in a woman with the FMR1 premutation and multiple sclerosis.
Arch Neurol, 65 (2008), pp. 1114-1116
[29.]
R.J. Hagerman, C. Greco, A. Chudley, M. Leehey, F. Tassone, J. Grigsby, et al.
Neuropathology and neurodegenerative features in some older male premutation carriers of fragile X syndrome.
Am J Hum Genet, 69 (2001), pp. 177
[30.]
K. Amiri, R.J. Hagerman, P.J. Hagerman.
Fragile X-associated tremor/ataxia syndrome: an aging face of the fragile X gene.
Arch Neurol, 65 (2008), pp. 19-25
[31.]
C. Raske, P.J. Hagerman.
Molecular pathogenesis of fragile X-associated tremor/ataxia syndrome.
J Investig Med, 57 (2009), pp. 825-829
[32.]
C.J. Moore, E.M. Daly, F. Tassone, C. Tysoe, N. Schmitz, V. Nag, et al.
The effect of premutation expansion of CGG trinucleotide repeats on brain anatomy.
Brain, 127 (2004), pp. 2672-2681
[33.]
M.B. Dorn, M.M.M. Mazzocco, R.J. Hagerman.
Behavioral and psychiatric disorders in adult male carriers of fragile X.
J Am Acad Child Adolesc Psychiatry, 33 (1994), pp. 256-264
[34.]
F. Tassone, R.J. Hagerman, A.K. Taylor, J.B. Mills, S.W. Harris, L.W. Gane.
Clinical involvement and protein expression in individuals with the FMR1 premutation.
Am J Med Genet, 91 (2000), pp. 144-152
[35.]
J.E. Riddle, A. Cheema, W.E. Sobesky, S.C. Gardner, A.K. Taylor, B.F. Pennington.
Phenotypic involvement in females with the FMR1 gene mutation.
Am J Ment Retard, 102 (1998), pp. 590-601
[36.]
J.E. Hunter, A. Abramowitz, M. Rusin, S.L. Sherman.
Is there evidence for neuropsychological and neurobehavioral phenotypes among adults without FXTAS who carry the FMR1 Premutation? A review of current literature.
Genet Med, 11 (2009), pp. 79-89
[37.]
G.F. Myers, M.M. Mazzocco, A. Maddalena, A.L. Reiss.
No widespread psychological effect of the fragile X premutation in childhood: evidence from a preliminary controlled study.
J Dev Behav Pediatr, 22 (2001), pp. 353-359
[38.]
J. Goodlin-Jones, F. Tassone, L.W. Gane, R.J. Hagerman.
Autistic spectrum disorder and fragile X premutation.
J Dev Behav Padiatr, 25 (2004), pp. 392-398
[39.]
H. Van Esch.
The fragile X premutation: new insights and clinical consequences.
Eu J Med Genet, 49 (2006), pp. 1-8
[40.]
D.B. Bailey, M. Raspa, M. Olmsted, D.B. Holiday.
Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey.
Am J Med Genetics, 146A (2008), pp. 2060-2069
[41.]
S. Clifford, C. Dissanayake, Q.M. Bui, R. Huggins, A.K. Taylor, D.Z. Loesch.
Autism spectrum phenotype in male and females with fragile X full mutation and premutation.
J Autism Dev Disord, 37 (2007), pp. 738-747
[42.]
S.L. Sherman.
Premature ovarian failure among fragile X premutation carriers: parent of origin effect?.
Am J Hum Genet, 67 (2000), pp. 11-13
[43.]
C. Johnston, S. Eliez, J. Dyer-Friedman, D. Hessl, B. Glaser, C. Blasey, et al.
Neurobehavioral phenotype in carriers of the fragile X premutation.
Am J Med Genet, 103 (2001), pp. 314-319
[44.]
S. Jacquemont, F. Farzin, D. Hall, M. Leehey, J. Grigsby, L. Zhang, et al.
Aging in individuals with the FMR1 mutation.
Am J Ment Retard, 109 (2004), pp. 154-164
[45.]
E. Berry-Kravis, F. Lewin, J. Wuu, M. Leehey, R. Hagerman, P. Hagerman, et al.
Tremor and ataxia in fragile X premutation carriers: blinded videotape study.
Ann Neurol, 53 (2003), pp. 616-623
[46.]
S. Jacquemont, R.J. Hagerman, M. Leehey, J. Grigsby, L. Zhang, J.A. Brunberg.
Fragile X premutation tremor/ataxia syndrome: molecular, clinical and neuroimaging correlates.
Am J Hum Genet, 72 (2003), pp. 869-873
[47.]
S. Bacalman, F. Farzin, J.A. Bourgeois, J. Cogswell, B.L. Goodlin-Jones, L.W. Gane, et al.
Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: newly described fronto-subcortical dementia.
J Clin Psychiatry, 67 (2006), pp. 234-244
[48.]
E. Berry-Kravis, C.G. Goetz, M.A. Leehey, R.J. Hagerman, L. Zhang, L. Li, et al.
Neuropathic features in fragile X premutation carriers.
Am J Med Genet A, 143 (2007), pp. 19-26
[49.]
J.T. Al-Hinti, N. Nagan, S.I. Harik.
Fragile X premutation in a woman with cognitive impairment, tremor and history of premature ovarian failure.
Alzheimer Dis Assoc Dis, 21 (2007), pp. 262-264
[50.]
D.A. Hall, R.J. Hagerman, P.J. Hagerman, S. Jacquemont, M.A. Leehey.
Prevalence of FMR1 repeat expansions in movement disorders. A systematic review.
Neuroepidemiology, 26 (2006), pp. 151-155
[51.]
S. Jacquemont, M.A. Leehey, R.J. Hagerman, L.A. Beckett, P.J. Hagerman.
Size bias of fragile X premutation alleles in late-onset movement disorders.
J Med Genetics, 43 (2006), pp. 804-809
[52.]
Niranjan NS, Thomas FP. Fragile X-associated tremor/ataxia syndrome. MedLink Neurology [quoted Feb 2009]. Available at: www.medlink.com.
[53.]
D.A. Hall, K. Howard, R.J. Hagerman, M.A. Leehey.
Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease.
Parkinsonism Relat Disord, 15 (2009), pp. 156-159
[54.]
K. Soontarapornchai, R. Maselli, G. Fenton-Farrell, F. Tassone, P.J. Hagerman, D. Hessl, et al.
Abnormal nerve conduction features in fragile X premutation carriers.
Arch Neurol, 65 (2008), pp. 495-498
[55.]
M.A. Leehey, R.P. Munhoz, A.E. Lang, J. Brunberg, J. Grigsby, C. Greco, et al.
The fragile X premutation presenting as essential tremor.
Arch Neurol, 60 (2003), pp. 117-121
[56.]
P. Davous, R.J. Morales, C. Dupel-Pottier, E. Bertolle.
Fragile X premutation presenting as postural tremor and ataxia (FXTAS syndrome).
Rev Neurologique, 163 (2007), pp. 1091-1095
[57.]
G. Gorman, S. Fairgrieve, D. Birchall, P.F. Chinnery.
Fragile X premutation presenting as essential tremor.
J Neurol Neurosurg Psychiatry, 79 (2008), pp. 1195-1196
[58.]
D.Z. Loesch, L. Litewka, A. Churchyard, E. Gould, F. Tassone, M. Cook.
Tremor/ataxia syndrome and fragile X premutation: diagnostic caveats.
J Clin Neurosc, 14 (2007), pp. 245-248
[59.]
M.W. Kurz, A.M. Schlitter, Y. Klenk, T. Mueller, J.P. Larsen, D. Aarsland, et al.
FMR1 alleles in Parkinson's disease: relation to cognitive decline and hallucinations: a longitudinal study.
J Geriatr Psychiatr Neurol, 20 (2007), pp. 89-92
[60.]
M.A. Leehey, E. Berry-Kravis, C.G. Goetz, L. Zhang, L. Li, C.D. Rice, et al.
FMR1 CGG repeat length predicts motor dysfunction in premutation carriers.
Neurology, 70 (2008), pp. 1397-1402
[61.]
D.Z. Loesch, M.S. Khaniani, H.R. Slater, J.P. Rubio, Q.M. Bui, K. Kotschel, et al.
Small CGG repeat expansion alleles of FMR1 gene are associated with parkinsonism.
Clin Genet, 76 (2009), pp. 471-476
[62.]
R.J. Hagerman, D.A. Hall, S. Coffey, M. Leehey, J. Bourgeois, J. Gould, et al.
Treatment of fragile X-associates tremor ataxia syndrome (FXTAS) and related neurological problems.
Clin Interv Aging, 3 (2008), pp. 251-262
[63.]
J.A. Brunberg, S. Jacquemont, R.J. Hagerman, E.M. Berry-Kravis, J. Grigsby, M.A. Leethey, et al.
Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction.
Am J Neuroradiol, 23 (2003), pp. 1757-1766
[64.]
J.S. Adams, P.E. Adams, D. Nguyen, J.A. Bruberg, F. Tassone, W. Zhang, et al.
Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS).
Neurology, 69 (2007), pp. 851-859
[65.]
D.Z. Loesch, L. Litewka, P. Brotchie, R.M. Huggins, F. Tassone, M. Cook.
Magnetic resonance imaging study in older fragile X premutation male carriers.
Ann Neurol, 58 (2005), pp. 326-330
[66.]
A. McConkie-Rosell, L. Abrams, B. Finucane, A. Cronister, L.W. Gane, S.M. Coffey, et al.
Recommendations from multi-disciplinary focus groups on cascade testing and genetic counselling for Fragile X-associated disorders.
J Genet Counsel, 16 (2007), pp. 593-606
[67.]
E. Berry-Kravis, L. Abrams, S.M. Coffey, D.A. Hall, C. Greco, L.W. Gane, et al.
Fragile X-associated Tremor/Ataxia Syndrome: clinical features, genetics and testing guidelines.
Mov Dis, 22 (2007), pp. 2018-2030
[68.]
H. Deng, W. Le, J. Jankovic.
Premutation alleles associated with Parkinson disease and essential tremor.
JAMA, 292 (2004), pp. 1685-1686
[69.]
E.K. Tan, Y. Zhao, K.Y. Puong, H.Y. Law, L.L. Chan, K. Yew, et al.
Fragile X premutation alleles in SCA, ET and parkinsonism in an Asian cohort.
Neurology, 63 (2004), pp. 362-363
[70.]
A.H.O. Reis, A.C.S. Ferreira, K.B. Gomes, M.J.B. Aguiar, C.G. Fonseca, F.E. Cardoso, et al.
Frecuency of FMR1 premutation in individuals with ataxia and/or tremor and/or parkinsonismo.
Genet Mol Res, 7 (2008), pp. 74-84
[71.]
J.A. Bourgeois, J.B. Cogswell, D. Hessl, L. Zhang, M.Y. Ono, F. Tassone, et al.
Cognitive, anxiety and mood disorders in fragile X-associated tremor/ataxia syndrome.
Gen Hosp Psychiatry, 29 (2007), pp. 349-356
[72.]
E. Cellini, P. Forleo, A. Ginestroni, B. Nacmias, A. Tedde, S. Bagnoli, et al.
Fragile X premutation with atypical symptoms at onset.
Arch Neurol, 63 (2006), pp. 1135-1138
[73.]
J.M. Milunsky, T.A. Maher.
Fragile X carrier screening and spinocerebellar ataxia in older males.
Am J Med Genet, 125A (2004), pp. 320
[74.]
A. Brussino, C. Gellera, A. Saluto, C. Mariotti, C. Arduino, B. Castellotti, et al.
FMR1 gene premutation is a frequent genetic cause of late-on-set sporadic cerebellar ataxia.
Neurology, 64 (2005), pp. 145-147
[75.]
H. Van Esch, G. Matthijs, J.P. Fryns.
Should we screen for FMR1 premutations in female subjects presenting with ataxia?.
Ann Neurol, 57 (2005), pp. 932-933
[76.]
S. Menachem, A. Lossos.
Cerebellar T2 hyperintensities in a patient with tremor.
Neurology, 70 (2008), pp. 578
[77.]
L. Zhang, S. Coffey, L.L. Lua, C.M. Greco, J.A. Schafer, J. Brunberg, et al.
FMR1 premutation in females diagnosed with multiple sclerosis.
J Neurol Neurosurg Psychiatr, 80 (2009), pp. 812-814
[78.]
L. Rodriguez-Revenga, M.M. Santos, A. Sanchez, M. Pujol, B. Gomez-Anson, C. Badenas, et al.
Screening for FXTAS in 95 Spanish patients negative for Huntington disease.
Genet Test, 12 (2008), pp. 135-138
Copyright © 2010. Sociedad Española de Neurología
